Cubist Systematic Strategies’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$586K Sell
27,469
-328,143
-92% -$7.76M 0.01% 2200
2025
Q2
$7.67M Sell
355,612
-167,417
-32% -$3.11M 0.08% 757
2025
Q1
$8.69M Sell
523,029
-111,491
-18% -$2.03M 0.11% 557
2024
Q4
$11.6M Buy
+634,520
New +$10.2M 0.19% 398
2024
Q3
Sell
-666,578
Closed -$10.8M 2921
2024
Q2
$10.8M Buy
666,578
+215,060
+48% +$3.47M 0.19% 363
2024
Q1
$8.35M Buy
451,518
+66,273
+17% +$1.64M 0.1% 635
2023
Q4
$12.1M Buy
+385,245
New +$9.2M 0.15% 353
2023
Q3
Sell
-114,062
Closed -$2.73M 3265
2023
Q2
$2.73M Sell
114,062
-150,109
-57% -$3.34M 0.03% 1260
2023
Q1
$4.97M Buy
264,171
+253,282
+2,326% +$4.82M 0.05% 933
2022
Q4
$173K Sell
10,889
-91,936
-89% -$1.44M ﹤0.01% 3646
2022
Q3
$1.68M Buy
102,825
+74,952
+269% +$1.21M 0.01% 2175
2022
Q2
$393K Sell
27,873
-109,010
-80% -$2.03M ﹤0.01% 3241
2022
Q1
$3.31M Buy
136,883
+92,063
+205% +$2.23M 0.03% 1064
2021
Q4
$1.05M Sell
44,820
-88,106
-66% -$1.77M 0.01% 1879
2021
Q3
$2.21M Buy
132,926
+55,160
+71% +$1.06M 0.03% 947
2021
Q2
$1.9M Buy
77,766
+33,151
+74% +$748K 0.02% 1109
2021
Q1
$1.15M Sell
44,615
-55,993
-56% -$2.46M 0.01% 1448
2020
Q4
$5.38M Buy
100,608
+77,896
+343% +$3.87M 0.07% 410
2020
Q3
$937K Sell
22,712
-242,534
-91% -$10.5M 0.01% 1374
2020
Q2
$12.9M Buy
+265,246
New +$12.7M 0.22% 72
2020
Q1
Sell
-35,348
Closed -$1.51M 2130
2019
Q4
$1.51M Sell
35,348
-61,828
-64% -$2.69M 0.03% 908
2019
Q3
$3.5M Buy
97,176
+89,913
+1,238% +$2.73M 0.07% 419
2019
Q2
$194K Sell
7,263
-111,762
-94% -$2.85M ﹤0.01% 2061
2019
Q1
$3.2M Buy
119,025
+113,647
+2,113% +$2.65M 0.1% 264
2018
Q4
$87K Sell
5,378
-22,566
-81% -$438K ﹤0.01% 1784
2018
Q3
$580K Sell
27,944
-1,711
-6% -$26.9K 0.03% 736
2018
Q2
$453K Buy
29,655
+19,093
+181% +$340K 0.02% 845
2018
Q1
$237K Buy
10,562
+5,396
+104% +$149K 0.01% 1298
2017
Q4
$156K Sell
5,166
-4,412
-46% -$141K 0.01% 1610
2017
Q3
$361K Buy
9,578
+6,929
+262% +$225K 0.02% 1033
2017
Q2
$74K Sell
2,649
-5,025
-65% -$150K ﹤0.01% 1495
2017
Q1
$264K Buy
7,674
+1,007
+15% +$35.5K 0.02% 998
2016
Q4
$192K Buy
6,667
+4,306
+182% +$114K 0.02% 1281
2016
Q3
$75K Sell
2,361
-14,969
-86% -$508K ﹤0.01% 1518
2016
Q2
$563K Buy
17,330
+11,116
+179% +$372K 0.03% 693
2016
Q1
$174K Sell
6,214
-50,602
-89% -$1.1M 0.01% 1268
2015
Q4
$2.02M Sell
56,816
-31,242
-35% -$1.1M 0.12% 223
2015
Q3
$2.91M Buy
88,058
+39,058
+80% +$1.63M 0.15% 138
2015
Q2
$2.05M Buy
49,000
+48,700
+16,233% +$1.88M 0.1% 263
2015
Q1
$10K Sell
300
-1,358
-82% -$46.7K ﹤0.01% 1835
2014
Q4
$53K Sell
1,658
-4,494
-73% -$127K ﹤0.01% 1770
2014
Q3
$152K Buy
6,152
+1,252
+26% +$29.3K 0.01% 1460
2014
Q2
$111K Buy
+4,900
New +$102K 0.01% 1307

Other funds holding ACAD